SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-040757
Filing Date
2024-10-10
Accepted
2024-10-10 17:02:21
Documents
13
Period of Report
2024-10-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 35994
  Complete submission text file 0001493152-24-040757.txt   210114

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cocp-20241009.xsd EX-101.SCH 3036
3 XBRL LABEL FILE cocp-20241009_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE cocp-20241009_pre.xml EX-101.PRE 24179
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3546
Mailing Address 19805 N. CREEK PARKWAY BOTHELL WA 98011
Business Address 19805 N. CREEK PARKWAY BOTHELL WA 98011 (786) 459-1831
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38418 | Film No.: 241365768
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)